IBC Legal is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Axinn has more than 40 full time antitrust lawyers working on M&A, litigation, criminal and conduct investigations. Axinn has been global lead on mergers worth more than $400 billion, including: Dell’s $67 billion acquisition of EMC; Thermo Fisher’s $13.2 billion acquisition of life technologies; Ball Corporation’s $6 billion acquisition of Rexam; Johnson Controls’ $2 billion sale of Scott Safety to 3M; and McKesson’s $3.4 billion joint venture with Change Healthcare. Axinn has extensive experience in major trials and class actions, including In Re Blue Cross antitrust litigation (for IBC), Poultry Growers antitrust litigation (for Tyson Foods), SawStop (for Stanley Black & Decker), biosimilar antitrust litigation (for Momenta), German and Asian Auto Parts litigation, as well as monopolization and conspiracy cases for Thermo Fisher, Danfoss, Hexcel, University of Pittsburgh Medical Center and Affinia. The firm has litigated six merger cases brought by government agencies (winning five) and has a strong presence and track record in ongoing DOJ criminal antitrust matters and related litigation, including in auto parts and air cargo. The antitrust group has extensive experience on matters involving antitrust and IP issues, including Google’s settlement with the Federal Trade Commission on standard essential patents and is lead counsel in a major litigation involving biosimilars. Axinn has deep contacts with the staff and front offices of FTC and DOJ in both Republican and Democratic administrations and employs lawyers with more than 60 years of government antitrust experience.